New Meningitis Vaccine from Novartis on the Anvil

by Kathy Jones on  December 27, 2010 at 11:34 PM Corporate News   - G J E 4
A new vaccine against meningitis B is likely to be unveiled sometime next year with Novartis revealing that the jab has been successfully tested among humans.
 New Meningitis Vaccine from Novartis on the Anvil
New Meningitis Vaccine from Novartis on the Anvil

Novartis' drug, Bexsero has been lauded by health experts who say that the vaccine will help see a sharp drop in the number of children dying due to the disease to which no protection is currently available.

According to Novartis, the vaccine has been successful in trials in which more than 7,500 children, adolescents and adults took part with the vaccine producing antibodies against more than 77 percent of more than 800 meningitis B strains.

Says Andrin Oswald, Head of Novartis Vaccines and Diagnostics Division, "The Bexsero submission in the EU is an important milestone toward achieving the world's first broad-coverage MenB vaccine through our unique multi-component approach."

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like